Cetera Trust Company, N.A Neurocrine Biosciences Inc Transaction History
Cetera Trust Company, N.A
- $167 Billion
- Q2 2025
A detailed history of Cetera Trust Company, N.A transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Cetera Trust Company, N.A holds 2,430 shares of NBIX stock, worth $332,982. This represents 0.18% of its overall portfolio holdings.
Number of Shares
2,430
Previous 2,190
10.96%
Holding current value
$332,982
Previous $242 Million
26.1%
% of portfolio
0.18%
Previous 0.15%
Shares
3 transactions
Others Institutions Holding NBIX
# of Institutions
657Shares Held
101MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.94 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.34 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$763 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$612 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$423 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...